Systematic Review and Meta-Analysis: Preoperative Vedolizumab Treatment and Postoperative Complications in Patients with Inflammatory Bowel Disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic Review and Meta-Analysis: Preoperative Vedolizumab Treatment and Postoperative Complications in Patients with Inflammatory Bowel Disease
Authors
Keywords
-
Journal
Journal of Crohns & Colitis
Volume 12, Issue 5, Pages 538-545
Publisher
Oxford University Press (OUP)
Online
2018-02-22
DOI
10.1093/ecco-jcc/jjy022
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Perioperative Use of Vedolizumab is not Associated with Postoperative Infectious Complications in Patients with Ulcerative Colitis Undergoing Colectomy
- (2017) Marc Ferrante et al. Journal of Crohns & Colitis
- Risk Associated With Complications and Mortality After Urgent Surgery vs Elective and Emergency Surgery
- (2017) Matthew G. Mullen et al. JAMA Surgery
- Short and Long-Term Outcomes After Surgical Procedures Lasting for More Than Six Hours
- (2017) Natalia Cornellà et al. Scientific Reports
- The safety of vedolizumab for ulcerative colitis and Crohn's disease
- (2016) Jean-Frédéric Colombel et al. GUT
- Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel Disease
- (2016) Amy L. Lightner et al. Journal of Crohns & Colitis
- The role of vedolizumab in patients with moderate-to-severe Crohn’s disease and ulcerative colitis
- (2016) Neal Shahidi et al. Therapeutic Advances in Gastroenterology
- Vedolizumab for the treatment of ulcerative colitis
- (2015) Neal Shahidi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Current and Emerging Biologics for Ulcerative Colitis
- (2015) Sung Chul Park et al. Gut and Liver
- The excess morbidity and mortality of emergency general surgery
- (2015) Joaquim M. Havens et al. Journal of Trauma and Acute Care Surgery
- The global burden of IBD: from 2015 to 2025
- (2015) Gilaad G. Kaplan Nature Reviews Gastroenterology & Hepatology
- How to read a funnel plot in a meta-analysis
- (2015) Philip Sedgwick et al. BMJ-British Medical Journal
- How to read a funnel plot in a meta-analysis
- (2015) Philip Sedgwick et al. BMJ-British Medical Journal
- The excess morbidity and mortality of emergency general surgery
- (2015) Joaquim M. Havens et al. Journal of Trauma and Acute Care Surgery
- PRISMA—Efficacy and Safety of Vedolizumab for Inflammatory Bowel Diseases
- (2015) Man Cai Wang et al. MEDICINE
- Preoperative infliximab use and postoperative complications in Crohn's disease: A systematic review and meta-analysis
- (2014) Zhi-Ping Yang et al. International Journal of Surgery
- Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease
- (2013) N. Narula et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: A systematic review and meta-analysis
- (2013) Greg Rosenfeld et al. Journal of Crohns & Colitis
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meta-analysis: effect of preoperative infliximab use on early postoperative complications in patients with ulcerative colitis undergoing abdominal surgery
- (2012) Z. Yang et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Use of Acid-Suppressive Drugs and Risk of Fracture: A Meta-analysis of Observational Studies
- (2011) C.-S. Eom et al. ANNALS OF FAMILY MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started